Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFusion Antibodies Regulatory News (FAB)

Share Price Information for Fusion Antibodies (FAB)

Share Price is delayed by 15 minutes
Get Live Data
13.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 1.00 (8.00%)
Market Cap: £16.25m
FAB Live PriceLast checked at - London Stock Exchange

Intraday Fusion Antibodies Share Chart

Update on development

11 Jul 2007 08:16

Fabian Romania Property Fund Ltd11 July 2007 11 July 2007 Fabian Romania Property Fund Limited ("Fabian Romania" or "Fabian") Construction contract agreed and sales started at the New Town residential joint venture development Fabian Romania is pleased to announce that its joint venture developmentcompany, Phoenix Park SRL, has agreed a fixed price build contract with MivanKier for residential apartments at the New Town development in east Bucharest. The development project is now forecast to involve the construction of more than635 residential apartments over two phases with an estimated gross developmentvalue in excess of €120 million and total costs, excluding land, ofapproximately €80 million. The apartments will be approximately 100 squaremetres per unit and are being targeted at middle income families. Building permits have been obtained and below ground construction works areongoing with the first apartments due to be completed in the summer of 2008. A sales and marketing suite was created in central Bucharest and a full launchhas started. To date, 119 apartments with parking have been released for salecomprising the first release. City wide newspaper and radio advertising has beentaken to support the launch. In July 2006, Fabian Romania paid €5.75 million for a 50 per cent. stake in thedevelopment company. Further development funding requirements are expected to bemet by a combination of bank financing and deposits from forward sales. MivanLtd of Country Antrim, Northern Ireland, through its Romanian operating companyRopotamo Expert SRL is acting as the development manager on the project as wellas being Fabian's joint venture partner. Mark Holdsworth, Director of Fabian Capital, Fabian Romania's investment advisersaid: "We are delighted with the progress of the New Town development and ourpartners Mivan. With build costs now secured and a full sales launch underway wehave made significant progress since entering into the joint venture last year.We will provide investors with a further progress report on how well theapartments are selling at the time of the publication of our second quarter NAV,expected on Monday 23 July." Enquiries: Fabian Romania: Mark Holdsworth +44 20 7499 9988 Nominated Adviser: Deloitte & Touche LLP James Lewis +44 20 7936 3000 Broker: Shore Capital Stockbrokers Limited Dru Danford +44 20 7408 4090 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
12th Nov 20207:00 amRNSNotice of Results
28th Oct 20204:41 pmRNSSecond Price Monitoring Extn
28th Oct 20204:36 pmRNSPrice Monitoring Extension
27th Oct 20207:00 amRNSReceipt of grants from Invest Northern Ireland
25th Sep 202011:38 amRNSResult of AGM
24th Sep 20202:39 pmRNSDirector/PDMR Shareholding
22nd Sep 20205:16 pmRNSHolding(s) in Company
18th Sep 20209:31 amRNSUpdate on R&D programme
28th Aug 20207:00 amRNSNotice of AGM
19th Aug 20207:00 amRNSFinal Results
11th Aug 20209:33 amRNSQueens University Belfast funding
31st Jul 20205:00 pmRNSTotal Voting Rights
7th Jul 20202:12 pmRNSExercise of Options
6th Jul 20204:41 pmRNSSecond Price Monitoring Extn
6th Jul 20204:36 pmRNSPrice Monitoring Extension
6th Jul 20207:00 amRNSTrading update
4th Jun 202012:57 pmRNSHolding(s) in Company
29th May 20205:00 pmRNSTotal Voting Rights
21st May 20206:24 pmRNSHolding(s) in Company
21st May 20202:52 pmRNSHolding(s) in Company
15th May 20204:49 pmRNSHolding(s) in Company
15th May 202010:47 amRNSResult of General Meeting & Total Voting Rights
15th May 20208:30 amRNSHolding(s) in Company
28th Apr 20207:00 amRNSPlacing to raise £3m, trading update, notice of GM
17th Apr 20204:41 pmRNSSecond Price Monitoring Extn
17th Apr 20204:35 pmRNSPrice Monitoring Extension
16th Apr 20204:41 pmRNSSecond Price Monitoring Extn
16th Apr 20204:36 pmRNSPrice Monitoring Extension
16th Apr 20203:51 pmRNSResearch Alliance with Queen’s University Belfast
16th Apr 20202:06 pmRNSSecond Price Monitoring Extn
16th Apr 20202:01 pmRNSPrice Monitoring Extension
30th Mar 20207:00 amRNSTrading update
19th Mar 20207:00 amRNSBelfast investor presentation
17th Mar 20207:00 amRNSDirector/PDMR Shareholding
17th Feb 20207:00 amRNSBelfast investor presentation
3rd Feb 202012:01 pmRNSDirector/PDMR Shareholding
30th Jan 20204:40 pmRNSSecond Price Monitoring Extn
30th Jan 20204:35 pmRNSPrice Monitoring Extension
29th Jan 20207:00 amRNSTrading update
10th Jan 202011:47 amRNSDirector/PDMR Shareholding
3rd Dec 20199:26 amRNSDirector/PDMR Shareholding
2nd Dec 20197:00 amRNSHalf-year Report
26th Nov 201911:13 amRNSNotice of Results
22nd Oct 20197:00 amRNSHalf year trading update
26th Sep 20199:54 amRNSDirector/PDMR Shareholding
20th Sep 20192:14 pmRNSResult of AGM
21st Aug 20197:00 amRNSPosting of Annual Report & Notice of AGM
3rd Jul 20194:09 pmRNSDirector/PDMR Shareholding
2nd Jul 20197:00 amRNSFinal Results
29th Apr 20192:46 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.